SIG, a Leading Building Products Specialists in Europe, Chooses Retail Merchandising Platform Elevaate as Partner.
Elevaate today announced SIG, one Europe’s leading building materials specialists, is turning to Elevaate for support in creating a more flexible and collaborative relationship with its supplier community.
“As leading specialist working across the European construction industry we work with a huge number of suppliers of different sizes and sophistication in a wide variety of countries. Elevaate gives us the agility to handle such diversity and has an offering designed to support stronger collaboration with our supplier community”, said Gareth Wray, eCommerce Director. “We’ve been impressed with Elevaate’s solution and believe they’re the right partner to help scale our digital merchandising operations in a very accountable way.”
“SIG, founded nearly 60 years ago, is a great example of an established company having the forward vision to modernize its retail technology and merchandising platforms to meet the growing demands of a digitally driven economy”, said Ken Platt, COO of Elevaate. “The flexibility and real-time data Elevaate provides will allow our Customer Success Managers to support the SIG team in optimizing valuable digital trade funded revenues and more collaborative supplier relationships.”
SIG has selected Elevaate to:
+ Help accelerate the digital transformation of their ecommerce merchandising to a more efficient, scalable platform
+ Improve supplier collaboration with real-time, in-day trading agility for both the internal team and their partners
+ Provide rich transaction data and experienced Customer Success Managers that can drive fresh thinking and better ROI for the business
SIG is a leading distributor of specialist building products in Europe. The Group has a product and service offering of significant scale with strong positions in its three core product areas of Insulation and Energy Management, Exteriors and Interiors. SIG operates from trading sites across the UK and Ireland and Mainland Europe and employs just over 9,000 people. The Group's main countries of operation are the UK, France and Germany, which together account for 88% of its continuing revenues.
Elevaate helps retailers and suppliers combine rich real-time transaction data with the commercial expertise of their people to optimise trade funded activity online. Commercial teams can now overcome the limitations of legacy systems and slow, traditional execution. Agile, accountable and transparent, Elevaate is a highly efficient SaaS platform designed by retail experts and technologists to transform the value of commercial relationships. Headquartered in the UK, Elevaate has served over 270 million products since launching in April 2015 to customers across Europe and Australia. Learn more at elevaate.com .
David Shearer, CMO
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
ADC-THERAPEUTICS11.12.2017 07:32 | pressemeddelelse
ADC Therapeutics Announces Interim Phase I Data from its Novel Antibody-Drug Conjugate ADCT-301
ADC-THERAPEUTICS11.12.2017 07:02 | pressemeddelelse
ADC Therapeutics Presents Interim Phase I Data from its Novel Antibody-Drug Conjugate ADCT-402
FL-GA-TELESIS11.12.2017 06:03 | pressemeddelelse
GA Telesis Launches Leveraged Finance Group with the Appointments of David Lloyd and Nolan Heske
ASTRAZENECA10.12.2017 23:47 | pressemeddelelse
AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials
NJ-CELGENE/BLUEBIRD-BIO10.12.2017 16:32 | pressemeddelelse
Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
GA-GILEAD-SCIENCES/KITE10.12.2017 16:32 | pressemeddelelse
Kite Announces Long-Term Data From Pivotal ZUMA-1 Study of Yescarta™ (Axicabtagene Ciloleucel) in Patients With Refractory Large B-cell Lymphoma
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum